Page last updated: 2024-10-28

halothane and Pantothenate Kinase-Associated Neurodegeneration

halothane has been researched along with Pantothenate Kinase-Associated Neurodegeneration in 1 studies

Pantothenate Kinase-Associated Neurodegeneration: A rare autosomal recessive degenerative disorder which usually presents in late childhood or adolescence. Clinical manifestations include progressive MUSCLE SPASTICITY; hyperreflexia; MUSCLE RIGIDITY; DYSTONIA; DYSARTHRIA; and intellectual deterioration which progresses to severe dementia over several years. (From Adams et al., Principles of Neurology, 6th ed, p972; Davis & Robertson, Textbook of Neuropathology, 2nd ed, pp972-929)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Roy, RC1
McLain, S1
Wise, A1
Shaffner, LD1

Other Studies

1 other study available for halothane and Pantothenate Kinase-Associated Neurodegeneration

ArticleYear
Anesthetic management of a patient with Hallervorden-Spatz disease.
    Anesthesiology, 1983, Volume: 58, Issue:4

    Topics: Adult; Anesthesia, Inhalation; Basal Ganglia Diseases; Female; Halothane; Humans; Intubation, Gastro

1983